doxorubicin hydrochloride (Sagent Pharmaceuticals)
Welcome to the PulseAid listing for the doxorubicin hydrochloride drug offered from Sagent Pharmaceuticals. This Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [Chemical/Ingredient],Topoisomerase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Sagent Pharmaceuticals |
NON-PROPRIETARY NAME: | doxorubicin hydrochloride |
SUBSTANCE NAME: | DOXORUBICIN HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [Chemical/Ingredient],Topoisomerase Inhibitors [MoA] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2013-10-31 |
END MARKETING DATE: | 0000-00-00 |
doxorubicin hydrochloride HUMAN PRESCRIPTION DRUG Details:
Item Description | doxorubicin hydrochloride from Sagent Pharmaceuticals |
LABELER NAME: | Sagent Pharmaceuticals |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 2(mg/mL) |
START MARKETING DATE: | 2013-10-31 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 25021-207_7b73261a-2590-441c-bff1-2d08972ee3d4 |
PRODUCT NDC: | 25021-207 |
APPLICATION NUMBER: | ANDA091495 |
Other DOXORUBICIN HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: